Rare diseases
Investigational molecules
Locations
Study on Infliximab and Azathioprine for Treating Complex Anal Fistulas in Patients Without Crohn's Disease
DenmarkStudy on Infliximab and Corticosteroids for Treating Severe Colitis Caused by Immune Checkpoint Inhibitors in Patients
DenmarkStudy on the Effectiveness of Infliximab for Children with Inflammatory Bowel Disease
ItalyStudy Comparing Methotrexate or Leflunomide with Targeted Therapy vs. Methotrexate or Leflunomide with Drug Combination for Rheumatoid Arthritis Patients
FranceAdd‑on Unsaturated Fatty Acids with TNF‑Alpha Inhibitor Drug Combination in Patients with Psoriatic Arthritis
ItalyOptimizing biologic tapering in patients with rheumatoid arthritis using tocilizumab, drug combination, and olfactory placebo conditioning
The NetherlandsMethoxsalen (ECP) versus drug combination for steroid‑refractory immune‑related colitis or hepatitis in metastatic melanoma on checkpoint therapy
AustriaMethotrexate tapering versus usual care in elderly (≥70) patients with rheumatoid arthritis in low disease activity – drug combination study
DenmarkSafety and efficacy of rilvegostomig with drug combination in adult patients with unresectable stage III non‑small cell lung cancer undergoing chemoradiotherapy
GermanyA study comparing vedolizumab, filgotinib, ustekinumab, and infliximab to maintain remission in patients with ulcerative colitis
FranceStudy on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features
BelgiumStudy on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis
FinlandTell us about your condition – we search every trial in Europe and connect you with the right site.
